These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 7044620

  • 1. Treatment of post menopausal osteoporosis. A controlled therapeutic trial comparing oestrogen/gestagen, 1,25-dihydroxy-vitamin D3 and calcium.
    Jensen GF, Christiansen C, Transbøl I.
    Clin Endocrinol (Oxf); 1982 May; 16(5):515-24. PubMed ID: 7044620
    [Abstract] [Full Text] [Related]

  • 2. Effect of 1,25-dihydroxy-vitamin D3 in itself or combined with hormone treatment in preventing postmenopausal osteoporosis.
    Christiansen C, Christensen MS, Rødbro P, Hagen C, Transbøl I.
    Eur J Clin Invest; 1981 Aug; 11(4):305-9. PubMed ID: 6795047
    [Abstract] [Full Text] [Related]

  • 3. Does 1,25(OH)2D3 accelerate spinal bone loss? A controlled therapeutic trial in 70-year-old women.
    Jensen GF, Meinecke B, Boesen J, Transbøl I.
    Clin Orthop Relat Res; 1985 Aug; (192):215-21. PubMed ID: 3881203
    [Abstract] [Full Text] [Related]

  • 4. Clinical, biochemical and histological results of a double-blind trial with 1,25-dihydroxyvitamin D3, estradiol and placebo in post-menopausal osteoporosis.
    Caniggia A, Delling G, Nuti R, Lorè F, Vattimo A.
    Acta Vitaminol Enzymol; 1984 Aug; 6(2):117-28. PubMed ID: 6388277
    [Abstract] [Full Text] [Related]

  • 5. Does calcium potentiate the bone-preserving effect of oestrogen treatment in early post-menopausal women by a change in vitamin D metabolism?
    Riis BJ, Christiansen C.
    Maturitas; 1984 Jul; 6(1):65-70. PubMed ID: 6381968
    [Abstract] [Full Text] [Related]

  • 6. Continuous oestrogen-progestogen treatment and bone metabolism in post-menopausal women.
    Riis BJ, Johansen J, Christiansen C.
    Maturitas; 1988 May; 10(1):51-8. PubMed ID: 3041248
    [Abstract] [Full Text] [Related]

  • 7. A randomized study on the effects of estrogen/gestagen or high dose oral calcium on trabecular bone remodeling in postmenopausal osteoporosis.
    Steiniche T, Hasling C, Charles P, Eriksen EF, Mosekilde L, Melsen F.
    Bone; 1989 May; 10(5):313-20. PubMed ID: 2690898
    [Abstract] [Full Text] [Related]

  • 8. Photon absorptiometry studies in osteoporosis.
    Christiansen C.
    Acta Obstet Gynecol Scand Suppl; 1985 May; 130():67-70. PubMed ID: 3893022
    [No Abstract] [Full Text] [Related]

  • 9. Effect of natural oestrogen/gestagen therapy on uric acid metabolism in post-menopausal women.
    Gotfredsen A, Christiansen C, Transbøl I.
    Maturitas; 1983 Jun; 5(1):9-15. PubMed ID: 6348486
    [Abstract] [Full Text] [Related]

  • 10. Serum bone Gla protein variations during estrogen and calcium prophylaxis of postmenopausal women.
    Pødenphant J, Christiansen C, Catherwood BD, Deftos LJ.
    Calcif Tissue Int; 1984 Sep; 36(5):536-40. PubMed ID: 6441624
    [Abstract] [Full Text] [Related]

  • 11. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 12. Serum alkaline phosphatase during hormone treatment in early postmenopausal women. A model for establishing optimal prophylaxis and treatment in postmenopausal osteoporosis.
    Christiansen C, Rødbro P, Tjellesen L.
    Acta Med Scand; 1984 Nov; 216(1):11-7. PubMed ID: 6385631
    [Abstract] [Full Text] [Related]

  • 13. 1,25(OH)2D3 and renal function. A controlled clinical study in normal elderly women.
    Jensen GF, Christiansen C, Transbøl I.
    Acta Med Scand; 1982 Nov; 211(1-2):51-4. PubMed ID: 7041522
    [Abstract] [Full Text] [Related]

  • 14. Long-term treatment of postmenopausal osteoporosis with active vitamin D3, 1-alpha-hydroxycholecalciferol (1 alpha-OHD3) and 1, 24 Dihydroxycholecalciferol (1, 24(OH)2D3).
    Shiraki M, Orimo H, Ito H, Akiguchi I, Nakao J, Takahashi R, Ishizuka S.
    Endocrinol Jpn; 1985 Apr; 32(2):305-15. PubMed ID: 2995014
    [Abstract] [Full Text] [Related]

  • 15. Uncoupling of bone formation and resorption by combined oestrogen and progestagen therapy in postmenopausal osteoporosis.
    Christiansen C, Riis BJ, Nilas L, Rødbro P, Deftos L.
    Lancet; 1985 Oct 12; 2(8459):800-1. PubMed ID: 2864532
    [Abstract] [Full Text] [Related]

  • 16. Five years with continuous combined oestrogen/progestogen therapy. Effects on calcium metabolism, lipoproteins, and bleeding pattern.
    Christiansen C, Riis BJ.
    Br J Obstet Gynaecol; 1990 Dec 12; 97(12):1087-92. PubMed ID: 2126198
    [Abstract] [Full Text] [Related]

  • 17. 17 Beta-estradiol and continuous norethisterone: a unique treatment for established osteoporosis in elderly women.
    Christiansen C, Riis BJ.
    J Clin Endocrinol Metab; 1990 Oct 12; 71(4):836-41. PubMed ID: 2205624
    [Abstract] [Full Text] [Related]

  • 18. Postmenopausal osteoporosis: no effect of three years treatment with 1,25-dihydroxycholecalciferol.
    Falch JA, Odegaard OR, Finnanger AM, Matheson I.
    Acta Med Scand; 1987 Oct 12; 221(2):199-204. PubMed ID: 3035879
    [Abstract] [Full Text] [Related]

  • 19. Changes in bone mineral content in women with natural menopause during treatment with female sex hormones.
    Dalén N, Furuhjelm M, Jacobson B, Lamke B.
    Acta Obstet Gynecol Scand; 1978 Oct 12; 57(5):435-7. PubMed ID: 726877
    [Abstract] [Full Text] [Related]

  • 20. Continuous treatment with natural oestrogens and progestogens. A method to avoid endometrial stimulation.
    Staland B.
    Maturitas; 1981 Aug 12; 3(2):145-56. PubMed ID: 7026979
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.